An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome

Drug Testing and Analysis

Volumn 8, Issue 5-6, 2016, Pages 539-548

  Cerniglia, Carl E ^a   Pineiro, Silvia A ^b   Kotarski, Susan F ^c  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c ZOETIS   (United States)

Author keywords

acceptable daily intake; antimicrobial agents; drug residues; microbiological effects; safety assessment

Indexed keywords

ANIMALS; BACTERIA; COPYRIGHTS; DRUG DOSAGE; ENVIRONMENTAL PROTECTION AGENCY; FOOD PRODUCTS; INTERNATIONAL COOPERATION;

'CURRENT; ACCEPTABLE DAILY INTAKES; ANIMAL-DERIVED FOOD; ANTIMICROBIAL DRUG; DRUG RESIDUE; INTESTINAL BACTERIA; MICROBIOLOGICAL EFFECT; MICROBIOME; REGULATORY AGENCIES; SAFETY ASSESSMENTS;

ANTIMICROBIAL AGENTS;

ANTIINFECTIVE AGENT; DRUG RESIDUE; VETERINARY DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; BODY WEIGHT; CONSUMER; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG SAFETY; FOOD CONTAMINATION; FOOD SAFETY; HUMAN; INTERNATIONAL COOPERATION; INTESTINE FLORA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH; RISK REDUCTION;

EID: 84979080270     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.2024     Document Type: Article

References (51)

1. VICH. Studies to evaluate the safety of residues of veterinary drugs in human food: General Approach to Testing-VICH Guideline 33 Recommended for Adoption at Step 7 of the VICH Process in February 2009 by the VICH SC for implementation in February 2010. VICH. Brussels, 2010.
2. VICH. Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. Guideline 36(R). Adopted at Step 7 of the VICH Process by the VICH Steering Committee in May 2012. VICH. Brussels, 2013.
3. VICH. Pre-approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance. Final guidance. VICH. Brussels, 2004.
4. US FDA/CVM (Food and Drug Administration Center for Veterinary Medicine). Guidance for Industry 152-Evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. US FDA/CVM. Rockville, MD, 2003.
5. FAO/WHO (Food and Agriculture Organization/World Health Organization). Joint FAO/WHO Expert Committee on Food Additives. FAO/WHO. Geneva, 2011.
6. A. M. O'Hara, F. Shanahan. The gut flora as a forgotten organ. EMBO Rep. 2006, 7, 688.
7. E. G. Zoetendal, M. Rajilic-Stojanovic, W. M. de Vos. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut. 2008, 57, 1605.
8. NIH Human Working Group, J. Peterson, S. Garges, M. Giovanni, P. McInnes, L. Wang, J. A. Schloss, V. Bonazzi, J. E. McEwen, K. A. Wetterstrand, C. Deal, C. C. Baker, V. Di Francesco, T. K. Howcroft, R. W. Karp, R. D. Lunsford, C. R. Wellington, T. Belachew, M. Wright, C. Giblin, H. David, M. Mills, R. Salomon, C. Mullins, B. Akolkar, L. Begg, C. Davis, L. Grandison, M. Humble, J. Khalsa, A. R. Little, H. Peavy, C. Pontzer, M. Portnoy, M. H. Sayre, P. Starke-Reed, S. Zakhari, J. Read, B. Watson, M. Guyer. The NIH Human Microbiome Project. Genome Res. 2009, 19, 2317.
9. J. Qin, R. Li, J. Raes, M. Arumugam, K. S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. Levenez, T. Yamada, D. R. Mende, J. Li, J. Xu, S. Li, D. Li, J. Cao, B. Wang, H. Liang, H. Zheng, Y. Xie, H. Zheng, J. Tap, P. Lepage, M. Bertalan, J. M. Batto, T. Hansen, D. Le Paslier, A. Linneberg, H. B. Nielsen, A. Linneberg, E. Pelletier, P. Renault, T. Sicheritz-Ponten, K. Turner, H. Zhu, C. Yu, S. Li, M. Jian, Y. Zhou, Y. Li, X. Zhang, S. Li, N. Qin, H. Yang, J. Wang, S. Brunak, J. Dore, F. Guarner, K. Kristiansen, O. Pedersen, J. Parkhill, J. Weissenbach, H. I. T. C. Meta, P. Bork, S. D. Ehrlich, J. Wang. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010, 464, 59.
10. M. Arumugam, J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D. R. Mende, G. R. Fernandes, J. Tap, T. Bruls, J. M. Batto, M. Bertalan, N. Borruel, F. Casellas, L. Fernandez, L. Gautier, T. Hansen, M. Hattori, T. Hayashi, M. Kleerebezem, K. Kurokawa, M. Leclerc, F. Levenez, C. Manichanh, H. B. Nielsen, T. Nielsen, N. Pons, J. Poulain, J. Qin, T. Sicheritz-Ponten, S. Tims, D. Torrents, E. Ugarte, E. G. Zoetendal, J. Wang, F. Guarner, O. Pedersen, W. M. deVos, S. Brunak, J. Dore, H. I. T. C. Meta, M. Antolin, F. Artiguenave, H. M. Blottiere, M. Almeida, C. Brechot, C. Cara, C. Chervaux, A. Cultrone, C. Delorme, G. Denariaz, R. Dervyn, K. U. Foerstner, C. Friss, M. van deGuchte, E. Guedon, F. Haimet, W. Huber, J. vanHylckama-Vlieg, A. Jamet, C. Juste, G. Kaci, J. Knol, O. Lakhdari, S. Layec, K. Le Roux, E. Maguin, A. Merieux, R. Melo Minardi, C. M'Rini, J. Muller, R. Oozeer, J. Parkhill, P. Renault, M. Rescigno, N. Sanchez, S. Sunagawa, A. Torrejon, K. Turner, G. Vandemeulebrouck, E. Varela, Y. Winogradsky, G. Zeller, J. Weissenbach, S. D. Ehrlich, P. P. Bork. Enterotypes of the human gut microbiome. Nature. 2011, 473, 174.
11. S. R. Gill, M. Pop, R. T. Deboy, P. B. Eckburg, P. J. Turnbaugh, B. S. Samuel, J. I. Gordon, D. A. Relman, C. M. Fraser-Liggett, K. E. Nelson. Metagenomic analysis of the human distal gut microbiome. Science. 2006, 312, 1355.
12. A. Y. Voigt, P. I. Costea, J. R. Kultima, S. S. Li, G. Zeller, S. Sunagawa, P. Bork. Temporal and technical variability of human gut metagenomes. Genome Biol. 2015, 16, 73.
13. F. Backhed, H. Ding, T. Wang, L. V. Hooper, G. Y. Koh, A. Nagy, C. F. Semenkovich, J. I. Gordon. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 15718.
14. J. C. Lagier, M. Million, P. Hugon, F. Armougom, D. Raoult. Human gut microbiota: repertoire and variations. Front Cell Infect. Microbiol. 2012, 2, 136.
15. T. Sousa, R. Paterson, V. Moore, A. Carlsson, B. Abrahamsson, A. W. Basit. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int. J. Pharm. 2008, 363, 1.
16. C. E. Cerniglia, S. Kotarski. Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora. Regul. Toxicol. Pharmacol. 1999, 29, 238.
17. C. E. Cerniglia, S. Kotarski. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. J. Vet. Pharmacol. Ther. 2005, 28, 3.
18. P. Silley. Impact of antimicrobial residues on gut communities: are the new regulations effective? J. Appl. Microbiol. 2007, 102, 1220.
19. J. H. Cummings, J. G. Banwell, I. Segal, N. Coleman, H. N. Englyst, G. Macfarlane. The amount and composition of large bowel contents in man. Gastroenterology. 1990, 5, 408.
20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. CLSI, Wayne, PA, 2007.
21. A. D. Badley, M. Camilleri, M. K. O'Connor. Noninvasive measurement of human ascending colon volume. Nucl. Med. Commun. 1993, 14, 485.
22. S. E. Pritchard, L. Marciani, K. C. Garsed, C. L. Hoad, W. Thongborisute, E. Roberts, P. A. Gowland, R. C. Spiller. Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI. Neurogastroenterol. Motil. 2014, 26, 124.
23. G. H. Wagman, J. V. Bailey, M. J. Weinstein. Binding of aminoglycosides to feces. Antimicrob. Agents Chemother. 1974, 6, 415.
24. M. P. Hazenberg, M. Van de Boom, M. Bakker, J. P. Van de Merwe. Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination. Antonie Van Leeuwenhoek. 1983, 49, 111.
25. M. P. Hazenberg, A. M. Pennock-Schroder, M. Van den Boom, J. P. Van de Merwe. Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces. J. Hyg. (Lond.). 1984, 93, 27.
26. E. M. Veringa, D. van der Waaij. Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract. J. Antimicrob. Chemother. 1984, 14, 605.
27. J. J. van Saene, H. K. van Saene, C. P. Stoutenbeek, C. F. Lerk. Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal. Scand. J. Infect. Dis. 1985, 17, 295.
28. C. Edlund, L. Lindqvist, C. E. Nord. Norfloxacin binds to human faecal material. Antimicrob. Agents Chemother. 1988, 32, 1869.
29. G. Jansen, F. Weissing, H. de Vries-Hospers, R. Tonk, D. van der Waaij. The non-enzymatic inactivation of thirteen beta-lactam antibiotics in human faeces. Infection. 1992, 20, 355.
30. C. Wiuff, J. Lykkesfeldt, F. M. Aarestrup, O. Svendsen. Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. J. Vet. Pharmacol. Ther. 2002, 25, 335.
31. Y. Ahn, S. W. Linder, B. T. Veach, S. Steve Yan, A. Haydee Fernandez, S. A. Pineiro, C. E. Cerniglia. In vitro enrofloxacin binding in human fecal slurries. Regul. Toxicol. Pharmacol. 2012, 62, 74.
32. B. S. Kim, J. N. Kim, S. H. Yoon, J. Chun, C. E. Cerniglia. Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis. Anaerobe. 2012, 18, 310.
33. M. Martinez, J. Blondeau, C. E. Cerniglia, J. Fink-Gremmels, S. Guenther, R. P. Hunter, X. Z. Li, M. Papich, P. Silley, S. Soback, P. L. Toutain, Q. Zhang. Workshop report: the 2012 antimicrobial agents in veterinary medicine: exploring the consequences of antimicrobial drug use: a 3-D approach. J. Vet. Pharmacol. Ther. 2014, 37, e1.
34. VICH. GL54 Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish an Acute Reference Dose (ARfD). Currently released at Step 4 for consultation and review (February 2015). VICH. Rockville, MD, 2015.
35. M. Camilleri, L. J. Colemont, S. F. Phillips, M. L. Brown, G. M. Thomforde, N. Chapman, A. R. Zinsmeister. Human gastric emptying and colonic filling of solids characterized by a new method. Am. J. Physiol. 1989, 257, G284.
36. N. W. Read, M. N. Al-Janabi, A. M. Holgate, D. C. Barber, C. A. Edwards. Simultaneous measurement of gastric emptying, small bowel residence and colonic filling of a solid meal by the use of the gamma camera. Gut. 1986, 27, 300.
37. M. Proano, M. Camilleri, S. F. Phillips, M. L. Brown, G. M. Thomforde. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am. J. Physiol. 1990, 258, G856.
38. S. E. Fleming, D. Marthinsen, H. Kuhnlein. Colonic function and fermentation in men consuming high fiber diets. J. Nutr. 1983, 113, 2535.
39. C. G. Wilson. The transit of dosage forms through the colon. Int. J. Pharm. 2010, 395, 17.
40. FAO/WHO (Food and Agriculture Organization/World Health Organization). Joint FAO/WHO Expert Committee on Food Additives. FAO/WHO. Geneva, 1997.
41. EMA (European Medicines Agency). Committee for Medicinal Products for Veterinary Use. EMA. London, 2000.
42. D. E. Corpet. Antibiotic residues and drug resistance in human intestinal flora. Antimicrob. Agents Chemother. 1987, 31, 587.
43. A. Perrin-Guyomard, S. Cottin, D. E. Corpet, J. Boisseau, J. M. Poul. Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model. Regul. Toxicol. Pharmacol. 2001, 34, 125.
44. R. J. Carman, M. A. Simon, H. E. Petzold 3rd, R. F. Wimmer, M. R. Batra, A. H. Fernandez, M. A. Miller, M. Bartholomew. Antibiotics in the human food chain: establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora. Regul. Toxicol. Pharmacol. 2005, 43, 168.
45. A. Perrin-Guyomard, J. M. Poul, D. E. Corpet, P. Sanders, A. H. Fernandez, M. Bartholomew. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model. Regul. Toxicol. Pharmacol. 2005, 42, 151.
46. A. Perrin-Guyomard, J. M. Poul, M. Laurentie, P. Sanders, A. H. Fernandez, M. Bartholomew. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model. Regul. Toxicol. Pharmacol. 2006, 45, 66.
47. R. D. Wagner, S. J. Johnson, C. E. Cerniglia. In vitro model of colonization resistance by the enteric microbiota: effects of antimicrobial agents used in food-producing animals. Antimicrob. Agents Chemother. 2008, 52, 1230.
48. H. Hao, W. Guo, Z. Iqbal, G. Cheng, X. Wang, M. Dai, L. Huang, Y. Wang, D. Peng, Z. Liu, Z. Yuan. Impact of cyadox on human colonic microflora in chemostat models. Regul. Toxicol. Pharmacol. 2013, 67, 335.
49. K.J. Greenlees, L.G. Friedlander, A. Boxall, in Chemical Analysis of Antibiotic Reisdues in Food. (Eds: J. Wang, J.D. MacNeil, J.F. Kay). John Wiley & Sons, Inc. New York, 2012.
50. P. Lees, T. Toutain in Chemical Analysis of Antibiotic Reisdues in Food. (Eds: J. Wang, J.D. MacNeil, J.F. Kay). John Wiley & Sons, Inc. New York, 2012.
51. L. W. Riley, E. Raphael, E. Faerstein. Obesity in the United States - dysbiosis from exposure to low-dose antibiotics? Front. Public Health. 2013, 1, 69.